Especially, the A allele in the IGFBP-3 promoter region reportedly causes an increase in IGFBP-3 expression, which reflects the growth rate in rhGH therapy in prepubertal children with GHD [38] and Turner syndrome [39], but not ISS [40]. Here, IGFBP3 is linked to Turner syndrome.